ECHA Committee Outcomes

1. PFAS Restriction Proposal: Major Step Forward

• RAC Position: the EU-wide restriction of thousands of PFAS based on their persistent, bioaccumulative, and toxic (PBT) properties.
• SEAC Status: Socio-economic analysis is ongoing. Final opinion expected by end of 2025.

🔍 Implications:

• Broad restriction likely by 2026.
• Affects textiles, food packaging, automotive, medical, electronics, and more.

✅ Action for Industry:

• Begin PFAS substitution planning and supply chain impact assessments.
• Engage with suppliers about PFAS-free alternatives.

2. Bisphenol A (BPA) – Binding OEL Recommended

• RAC Recommendation: Introduced a binding occupational exposure limit (OEL) for BPA, based on its endocrine-disrupting and reproductive toxicity.
• Next Step: Feed into updates under the Chemical Agents Directive (CAD).

🔍 Implications:

• Industries using BPA (plastics, coatings, electronics) must prepare for airborne exposure limits in workplaces.

✅ Action for Employers:

• Evaluate workplace BPA exposure levels.
• Plan updates to ventilation, PPE, and training protocols ahead of CAD adoption.

3. CLP Regulation – Harmonised Classification & Labelling (CLH) Updates

• Changes Approved:

o New or revised classifications for substances with CMR (carcinogenic, mutagenic, reprotoxic) or environmental toxicity.
o Addition of group classifications for structurally similar substances.

• New entries added to Annex VI of CLP Regulation.

🔍 Implications:

• Affects Safety Data Sheets (SDS), product labels, and chemical registration dossiers across the EU.

✅ Action for Chemical Manufacturers:

• Review all products against updated Annex VI classifications.
• Update labels, SDSs, and customer communications accordingly.

4. Regulatory Reform: CLP Classification Procedures (Reg. 2025/1222)

• Key Changes:

o Group submissions now encouraged for related substances.
o Greater transparency: All proposals must be pre-notified and published.
o Defined timelines: RAC opinions and Commission decisions now subject to clear deadlines.

🔍 Implications:

• More predictable classification process.
• Increased visibility of substances under regulatory review.

✅ Action for Stakeholders:

• Track classification proposals early.
• Engage during public comment periods.
• Prepare compliance updates ahead of legal changes.

References: